Andere Sprachen Enanta Pharmaceuticals, Inc.

Aktien

A1T7BJ

US29251M1062

ENTA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 28.06.2024			% 5 Tage	% 1. Jan.
12,97 ^USD	+2,37 %		+8,72 %	+37,83 %

07.05.	ENANTA PHARMACEUTICALS, INC. : Bewertung von JMP Securities zum Kaufen erhalten	ZM
06.05.	Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference	29.05.
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference	07.05.
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot	06.05.
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Posts Q2 Revenue $17.1M, vs. Street Est of $16.2M	06.05.
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	06.05.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET	06.05.
Enanta Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)	01.05.
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	30.04.
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer	30.04.
Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer	30.04.
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024	29.04.
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024	17.04.
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference	06.03.
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Reports Q1 Revenue $18M, vs. Street Est of $21.9M	07.02.
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot	07.02.
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET	07.02.
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	07.02.
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06.02.
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023	31.01.
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference	04.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Enanta Pharmaceuticals, Inc.

Aktien

A1T7BJ

US29251M1062

ENTA

Andere Sprachen

Filter